In previous studies, we showed that inhibition of oncogene drivers such as EGFR in NSCLC and BCR-ABL in CML caused a downregulation of glycolysis and an upregulation of OXPHOS [22, 23]. This evidence concerns the gene ABL1 and non-small cell lung carcinoma.